ALLY BIOTECH
A Powerhouse of technology in the THC marketplace
About Ally Biotech
We are committed to harnessing science to produce breakthrough THC products that have a profoundly positive impact on humanity.
Our water soluble THC, made with patented Lipofusion® delivery technology, can be utilized as a raw ingredient in a wide variety of formulations.
We also offer private label THC products that combine the power of THC with our leading edge nanoliposomal delivery technology to maximize efficacy and deliver remarkable, reliable benefits.
MEET THE TEAM
Francis Baczek
PRESIDENT
Francis Baczek
Francis has worked with many amazing chefs at restaurants all over the US. He began cooking edibles for Uncle Herb’s and quickly realized his love for creating cannabis edibles. This love has translated into Francis becoming an industry leader within Arizona and many other states to bring a robust business development strategy to Ally.
Charles C Johnson, PhD
CHIEF SCIENTIFIC OFFICER
Charles C Johnson, PhD
After earning his BA in Chemistry from Northwestern University and PhD in Analytical Chemistry from Virginia Tech, Dr Chuck refined his craft while working The Procter & Gamble Company, Koch Industries, and Danaher, and expanded his scope of knowledge while working and consulting for DuPont, BATF, FBI, Army Corps of Engineers, Chiyoda Engineering, Toyo Engineering, Japan Gas Company, Yamato, Fisher Scientific, VWR Scientific Products, among others. Chuck brings with him experience with FDA regulatory compliance, LEAN (TPS) principles in Product Development and Manufacturing, competitive market analysis, mergers and acquisitions and technical sales. More recently he has provided consultation services and served as the Chief Science and Operations Officer in the Hemp and Cannabis sectors, including industrial farming, extraction, refining, GMP production, nutraceuticals, and FDA compliance.
“While watching my father suffer from Rheumatoid Arthritis and the less-than-effective conventional, medical care that he received, which used long-term steroidal and NSAID treatments, immune suppressants, opioids and additional medication to treat the side-effects of the primary prescriptions, I resolved myself to find a better way. This emerging industry has provided me the opportunity to thrive in the pursuit of that better way.”